Loading stock data…
Cardio Diagnostics Holdings Inc (CDIO)
$1.55-0.08 (-4.90%)
Market ClosedLast close Jul 24
Cardio Diagnostics Holdings, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Cardio Diagnostics Holdings, Inc. in the Healthcare sector is trading at $1.55 with a market capitalization of $6M. The stock is currently near its 52-week low of $0.97, remaining 40.6% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 16 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 16) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2,680↓ | $3,555↑ | $2,855↓ | $7,475↑ | $940 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$1.78M↓ | -$1.46M↑ | -$1.71M↓ | -$1.68M↓ | -$1.63M |
| Net Income | -$1.79M↓ | -$1.47M↑ | -$1.71M↓ | -$1.68M↓ | -$1.64M |
Peer Comparison
JNJUNHPFE
Fundamentals
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targe...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$6.16M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.20
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-74.70%
Volume
Today's trading volume
1.20M
Recent News
Is DXC (DXC) Centralizing Digital And AI Leadership To Reframe Its Long-Term Competitiveness Story?
Earlier this month, DXC Technology appointed longtime executive Russell Jukes as its first Chief Digital Information Officer, giving him responsibility for leading the company’s end-to-end digital and AI agenda and internal technology environment. The move centralizes DXC’s digital, data, and AI efforts under a single leader, signaling a clearer push to embed AI across its services, operations, and workforce capabilities. Next, we’ll examine how consolidating DXC’s digital and AI leadership...
e.l.f. Beauty’s CDIO says she’s responsible for AI’s foundation, but that these tools aren’t an IT mandate
Ekta Chopra, the chief digital information officer of e.l.f. Beauty, acts as a champion of generative AI and helps make it pervasive across the company with AI tools that can assist employees with research inquiries, IT requests, and data analytics.
Cardio Diagnostics Holdings Second Quarter 2025 Earnings: US$0.97 loss per share (vs US$1.71 loss in 2Q 2024)
NasdaqCM:CDIO 1 Year Share Price vs Fair Value Explore Cardio Diagnostics Holdings's Fair Values from the Community and...